As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...

Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ocular health.

Covid-19 is still circulating, though it's weaker now. Experts say it’s not a major threat but advise maintaining strong ...

This month marks five years since the COVID-19 pandemic began. The SARS-CoV-2 virus was circulating for months, likely ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

The latest variant on the rise is LP.8.1. It’s increasing in Australia, making up close to one in five COVID cases in New ...

The following is a summary of “A viro-immunological model to characterize the antiviral effect of molnupiravir in SARS-CoV-2-infected outpatients: implication for treatment duration,” published in the ...

A new brief report published in the American Journal of Infection Control (AJIC) demonstrates that ActivePure’s Advanced Photohydrolysis (AP) Technology effectively and rapidly inactivates aerosolized ...

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

The technology's ability to rapidly and continuously inactivate viruses like SARS-CoV-2, RSV, and MPXV can significantly enhance infection control measures, especially in environments where ...